Axillary dissection versus no axillary dissection in patients with breast cancer and sentinel-node micrometastases (IBCSG 23-01): 10-year follow-up of a randomised, controlled phase 3 trial

Viviana Galimberti, Bernard F. Cole, Giuseppe Viale, +199

The Lancet Oncology

Surgical OncologyBreast OncologyMedicineIbcsg 23-01Breast Cancer +5

Codon-specific translation reprogramming promotes resistance to targeted therapy

Francesca Rapino, Sylvain Delaunay, Florian Rambow, +26

Nature

EngineeringNovel TherapyClinical TranslationTranslational AdvanceCodon-specific Translation +3

18F-fluoride PET/CT for assessing bone involvement in prostate and breast cancers

Nadia Withofs, Benjamin Grayet, Tino Tancredi, +8

Nuclear Medicine Communications

Efficacy and safety of nivolumab (NIVO) in patients with advanced melanoma (MEL) and poor prognostic factors who progressed on or after ipilimumab (IPI): Results from a phase II study (CheckMate 172).

Dirk Schadendorf, Paolo A. Ascierto, John B.A.G. Haanen, +16

Journal of Clinical Oncology

Neuro-oncologyOncologyMelanomaObjective Response RateClinical Trials +13

Biomarker Analysis in a Phase II Study of Sunitinib in Patients with Advanced Melanoma.

Lore Decoster, Isabelle Vande Broek, Bart Neyns, +8

PubMed

Ipilimumab induces simultaneous regression of melanocytic naevi and melanoma metastases

Florence Libon, J.E. Arrese, Andrée Rorive, +1

Clinical and Experimental Dermatology

Multicenter phase I clinical trial of daily and weekly RAD001 (everolimus) in combination with vinorelbine and trastuzumab in patients with HER-2-overexpressing metastatic breast cancer with prior resistance to trastuzumab.

Angelica Fasolo, Lorenzo Gianni, Andrée Rorive, +7

Cancer Research

Breast OncologyAkt/mtor ActivationPathologyPharmacotherapyPharmacodynamic Modeling +18

Recurrent In Situ Melanoma Successfully Treated with Ingenol Mebutate

Marion Mansuy, Nazli Nikkels‐Tassoudji, Jorge E. Arrese, +2

Dermatology and Therapy

Melanoma masquerading as nonmelanocytic lesions

Audrey Detrixhe, Florence Libon, Marion Mansuy, +6

Melanoma Research

Dermoscopic ImageTumoral PathologyAmelanotic MelanomaHistopathologyMelanoma +8

Multicenter phase I clinical trial of daily and weekly RAD001 in combination with vinorelbine and trastuzumab in patients with HER2-overexpressing metastatic breast cancer with prior resistance to trastuzumab

Guy Jérusalem, Véronique Dièras, Fátima Cardoso, +7

Journal of Clinical Oncology

Breast OncologyPharmacotherapyTumor BiologyPre-clinical PharmacologyMetronomic Therapy +17